Literature DB >> 15809291

Role of chloride ions in modulation of the interaction between von Willebrand factor and ADAMTS-13.

Raimondo De Cristofaro1, Flora Peyvandi, Roberta Palla, Silvia Lavoretano, Rossana Lombardi, Giuliana Merati, Federica Romitelli, Enrico Di Stasio, Pier Mannuccio Mannucci.   

Abstract

The degradation of von Willebrand factor (VWF) depends on the activity of a zinc protease (referred to as ADAMTS-13), which cleaves VWF at the Tyr(1605)-Met(1606) peptide bond. Little information is available on the physiological mechanisms involved in regulation of AD-AMTS-13 activity. In this study, the role of ions on the ADAMTS-13/VWF interaction was investigated. In the presence of 1.5 m urea, the protease cleaved multimeric VWF in the absence of NaCl at pH 8.00 and 37 degrees C, with an apparent k(cat)/K(m) congruent with 3.4 x 10(4) M(-1) s(-1), but this value decreased by approximately 10-fold in the presence of 0.15 M NaCl. Using several monovalent salts, the inhibitory effect was attributed mostly to anions, whose potency was inversely related to the corresponding Jones-Dole viscosity B coefficients (ClO(4)(-) > Cl(-) > F(-)). The specific inhibitory effect of anions was due to their binding to VWF, which caused a conformational change responsible for quenching the intrinsic fluorescence of the protein and reducing tyrosine exposition to bulk solvent. Ristocetin binding to VWF could reduce the apparent affinity and reverse the inhibitory effect of chloride. We hypothesize that, after secretion into the extracellular compartment, VWF is bound by chloride ions abundantly present in this milieu, becoming unavailable to proteolysis by AD-AMTS-13. Shear forces, which facilitate GpIbalpha binding (this effect being artificially obtained by ristocetin), can reverse the inhibitory effect of chloride, whose concentration gradient across the cell membrane may represent a simple but efficient strategy to regulate the enzymatic activity of ADAMTS-13.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809291     DOI: 10.1074/jbc.M501143200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  The thrombospondin-1 N700S polymorphism is associated with early myocardial infarction without altering von Willebrand factor multimer size.

Authors:  Jeffrey I Zwicker; Flora Peyvandi; Roberta Palla; Rossana Lombardi; Maria Teresa Canciani; Andrea Cairo; Diego Ardissino; Luisa Bernardinelli; Kenneth A Bauer; Jack Lawler; Pier Mannucci
Journal:  Blood       Date:  2006-05-09       Impact factor: 22.113

2.  Ristocetin-induced self-aggregation of von Willebrand factor.

Authors:  Massimiliano Papi; Giuseppe Maulucci; Marco De Spirito; Mauro Missori; Giuseppe Arcovito; Stefano Lancellotti; Enrico Di Stasio; Raimondo De Cristofaro; Alessandro Arcovito
Journal:  Eur Biophys J       Date:  2010-06-30       Impact factor: 1.733

3.  A shear-based assay for assessing plasma ADAMTS13 activity and inhibitors in patients with thrombotic thrombocytopenic purpura.

Authors:  Yue Han; Juan Xiao; Erica Falls; X Long Zheng
Journal:  Transfusion       Date:  2011-01-20       Impact factor: 3.157

Review 4.  Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.

Authors:  Suresh G Shelat; Jihui Ai; X Long Zheng
Journal:  Semin Thromb Hemost       Date:  2005-12       Impact factor: 4.180

5.  Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.

Authors:  Jing-Jiang Wu; Kazuo Fujikawa; Brad A McMullen; Dominic W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

Review 6.  Pathogenesis of thrombotic microangiopathies.

Authors:  X Long Zheng; J Evan Sadler
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

7.  Mechanistic studies on ADAMTS13 catalysis.

Authors:  Enrico Di Stasio; Stefano Lancellotti; Flora Peyvandi; Roberta Palla; Pier Mannuccio Mannucci; Raimondo De Cristofaro
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

8.  Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors.

Authors:  Stefano Lancellotti; Sergio Rutella; Vincenzo De Filippis; Nicola Pozzi; Bianca Rocca; Raimondo De Cristofaro
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

9.  The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus.

Authors:  Laura Oggianu; Stefano Lancellotti; Dario Pitocco; Francesco Zaccardi; Paola Rizzo; Francesca Martini; Giovanni Ghirlanda; Raimondo De Cristofaro
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 10.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.